Cleared Traditional

K182217 - Linear Cutter Staplers and Loading Unit...

K182217 is the FDA 510(k) clearance for Linear Cutter Staplers and Loading Unit... by Ezisurg (Suzhou) Medical Co., Ltd.. It is a Class 2 General & Plastic Surgery device (product code GDW) cleared through the Traditional 510(k) pathway after a 244-day FDA review.

K182217 · Ezisurg (Suzhou) Medical Co., Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2019
Decision
244d
Days
Class 2
Risk

K182217 is an FDA 510(k) clearance for the Linear Cutter Staplers and Loading Units for Single Use, Circular Staplers fo.... Classified as Staple, Implantable (product code GDW), Class II - Special Controls.

Submitted by Ezisurg (Suzhou) Medical Co., Ltd. (Suzhou, CN). The FDA issued a Cleared decision on April 16, 2019 after a review of 244 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4750 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Ezisurg (Suzhou) Medical Co., Ltd. devices

Submission Details

510(k) Number K182217 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 15, 2018
Decision Date April 16, 2019
Days to Decision 244 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
129d slower than avg
Panel avg: 115d · This submission: 244d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GDW Staple, Implantable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Mid-Link Consulting Co, Ltd.
Ying Xu

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GDW Staple, Implantable

All 157
Devices cleared under the same product code (GDW) and FDA review panel - the closest regulatory comparables to K182217.
Reach and CQ'ENCE Circular Staplers
K192566 · Reach Surgical, Inc. · Oct 2019
Signia Small Diameter Reloads
K191070 · Covidien · Sep 2019
OptiFix AT Absorbable Fixation System with Articulating Technology – 30 Fasteners, OptiFix AT Absorbable Fixation System with Articulating Technology – 15 Fasteners
K191287 · Davol Inc., Subsidiary of C.R. Bard · Jul 2019
Signia Circular Adapters (for use with Signia Staplers), Tri-Staple 2.0 Circular Reloads (for use with Signia Circular Adapters)
K182475 · Covidien · Mar 2019
FasTouch Absorbable Fixation System
K181668 · Via Surgical , Ltd. · Mar 2019
easyPPHTM Hemorrhoidal Stapler for Single Use
K183477 · Ezisurg Medical Co., Ltd. · Feb 2019